Safety results during the reviewed trials were generally reassuring: No serious adverse events were reported Short-term use was generally well tolerated Side-effect rates did not clearly exceed placebo rates Long-term safety is less certain because most studies lasted only a few weeks or months
Sattar N, Neeland IJ, Dahlqvist Leinhard O, Fernndez Land L, Bray R, Linge J, Rodriguez A (2025) Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial
It modulates the amount of water in the body and the movement of sodium into and out of cells is essential for proper cell-to-cell signaling
We should have forecasted better, CEO Lars Fruergaard Jrgensen told The Wall Street Journal late last year by way of apology
This can help with weight-loss, but it can also lead to devastating gastrointestinal side effects
Sermorelin is not a weight loss medication